secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0000816956-26-000006
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q4 sales up 7.9%, adjusted EPS $1.43; FY2026 guidance below 2025 adjusted EPS
--------------------------------------------------------------------------------

- Q4 sales $373.2M (+7.9% YoY); GAAP EPS $0.54 vs $1.08, adjusted EPS $1.43 vs $1.34.
- FY2025 sales $1.3747B (+5.2%); GAAP EPS $1.51 vs $4.25, adjusted EPS $4.59 vs $4.17.
- FY2026 guidance: revenue $1.345B-$1.375B (organic constant-currency growth 4.5%-6% ex-gastro), adj. EPS $4.30-$4.45.
- International Q4 revenue +17% (reported) vs domestic +1.4%; Orthopedic Surgery segment +13.2%.
- GAAP results weighed by ~$60M in Q4 operating charges including optimization and product rationalization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000081695626000006/0000816956-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000081695626000006/cnmd-20260128.htm
  HTML page:      https://secwatch.observer/filing/0000816956-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer